REV1 and cancer: Our studies in mice and in mammalian cells strongly indicate PCNA-ubiquitination is the predominant mode of DDT, and that a genetic ablation of REV1 does not sensitize murine and human cancer cells to various classes of clinically approved DNA damaging agents.